Drugmaker Ionis Pharmaceuticals Garners Analyst Praise For 'Pipeline Depth'
HC Wainwright initiates Ionis with Buy rating and $45 target, citing strong pipeline, solid revenue, and key clinical ...
This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including ...
Fintel on MSN7h
HC Wainwright & Co. Initiates Coverage of Ionis Pharmaceuticals (IONS) with Buy Recommendation
Fintel reports that on April 7, 2025, HC Wainwright & Co. initiated coverage of Ionis Pharmaceuticals (NasdaqGS:IONS) with a ...
TipRanks on MSN9h
Ionis Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of Ionis Pharmaceuticals (IONS) with a Buy rating and $45 price target Ionis is a commercial-stage biotech ...